No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Azacitidine / analogs & derivatives*
-
Azacitidine / therapeutic use
-
Core Binding Factor Alpha 3 Subunit / genetics
-
Cytogenetic Analysis
-
DNA Helicases / genetics*
-
Decitabine
-
Humans
-
Myelodysplastic Syndromes / drug therapy*
-
Myelodysplastic Syndromes / genetics*
-
Myelodysplastic Syndromes / pathology
-
Nuclear Proteins / genetics*
-
Prognosis
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
RNA, Neoplasm / genetics
-
RNA, Neoplasm / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
-
X-linked Nuclear Protein
Substances
-
Antimetabolites, Antineoplastic
-
Core Binding Factor Alpha 3 Subunit
-
Nuclear Proteins
-
RNA, Messenger
-
RNA, Neoplasm
-
Runx3 protein, human
-
Decitabine
-
DNA Helicases
-
ATRX protein, human
-
X-linked Nuclear Protein
-
Azacitidine